Literature DB >> 20946279

Effect of substance abuse on defibrillation threshold in patients with implantable cardioverter-defibrillator.

Shane A Perrine1, Raghavendra Nayak, Aditya S Bharadwaj, George McKelvey, Tamam Mohamad, Sony Jacob.   

Abstract

BACKGROUND: The use of recreational drugs has been observed to have deleterious effects on the heart. The aim of our study was to evaluate the effect of substance abuse on the defibrillation threshold (DFT) in patients with implantable cardioverter-defibrillators (ICDs).
METHODS: A retrospective analysis was conducted on patients who had undergone ICD placement at a tertiary university medical center in Detroit, Michigan. Subjects were identified based on self-reported drug use and placed into one of the three groups: controls, cocaine, and other illicit drugs. Due to a disparity in race among groups, the main analysis on DFT value was conducted on African-American patients only. Furthermore, exploratory analyses were conducted to investigate the effects of marijuana use and race on DFT values.
RESULTS: A history of cocaine use (n = 17) significantly increases DFT among African Americans (17.3 ± 8 Joule [J] vs 12.5 ± 5 J in cases vs controls, P < 0.05), while previous use of marijuana does not significantly influence DFT. African-American patients with a history of illicit drug use had indications for ICD implantation at an earlier age and that within the control (nondrug using) group; African Americans (n = 73) had higher DFT compared to Caucasians (n = 32), (14.5 ± 0.5 J vs 9.7 ± 0.6 J, P < 0.05).
CONCLUSIONS: A history of cocaine use in African Americans with ICD is a risk factor for high DFT and race itself (being African American) may be a risk for high DFT. Use of high-energy ICDs and other DFT lowering techniques may be considered for patients who have used or continue to use cocaine or in whom DFT testing cannot be performed at the time of implantation. ©2010, The Authors. Journal compilation ©2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20946279      PMCID: PMC3022948          DOI: 10.1111/j.1540-8159.2010.02907.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  14 in total

1.  Cardiovascular complications of cocaine use.

Authors:  R A Lange; L D Hillis
Journal:  N Engl J Med       Date:  2001-08-02       Impact factor: 91.245

2.  ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines).

Authors:  Gabriel Gregoratos; Jonathan Abrams; Andrew E Epstein; Roger A Freedman; David L Hayes; Mark A Hlatky; Richard E Kerber; Gerald V Naccarelli; Mark H Schoenfeld; Michael J Silka; Stephen L Winters
Journal:  J Am Coll Cardiol       Date:  2002-11-06       Impact factor: 24.094

3.  Interpretation of lesions of the cardiac conduction system in cocaine-related fatalities.

Authors:  Katarzyna Michaud; Marc Augsburger; Frank Sporkert; Marc Bollmann; Thomas Krompecher; Patrice Mangin
Journal:  J Forensic Leg Med       Date:  2007-05-09       Impact factor: 1.614

4.  Anaesthetic drugs and defibrillation threshold testing.

Authors:  Sony Jacob; Aril E Abraham; George McKelvey
Journal:  Drugs       Date:  2008       Impact factor: 9.546

5.  Halothane, isoflurane, and fentanyl increase the minimally effective defibrillation threshold of an implantable cardioverter defibrillator: first report in humans.

Authors:  Avi A Weinbroum; Aharon Glick; Yitzchak Copperman; Tamar Yashar; Valery Rudick; Ron Flaishon
Journal:  Anesth Analg       Date:  2002-11       Impact factor: 5.108

Review 6.  Cardiovascular system effects of marijuana.

Authors:  Reese T Jones
Journal:  J Clin Pharmacol       Date:  2002-11       Impact factor: 3.126

7.  Electrical dose for ventricular defibrillation of large and small animals using precordial electrodes.

Authors:  L A Geddes; W A Tacker; J P Rosborough; A G Moore; P S Cabler
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

8.  Habitual cocaine use is associated with high defibrillation threshold during ICD implantation.

Authors:  Jay Chen; R Haris Naseem; Owen Obel; Jose A Joglar
Journal:  J Cardiovasc Electrophysiol       Date:  2007-04-30

9.  Clinical characteristics and outcome of patients with high defibrillation thresholds. A multicenter study.

Authors:  A E Epstein; K A Ellenbogen; K A Kirk; G N Kay; S M Dailey; V J Plumb
Journal:  Circulation       Date:  1992-10       Impact factor: 29.690

Review 10.  Effect of drugs on defibrillation capacity.

Authors:  Anna Legreid Dopp; John M Miller; James E Tisdale
Journal:  Drugs       Date:  2008       Impact factor: 9.546

View more
  3 in total

1.  Amino-terminal Pro-B-Type Natriuretic Peptide Among Patients Living With Both Human Immunodeficiency Virus and Heart Failure.

Authors:  Raza M Alvi; Markella V Zanni; Anne M Neilan; Malek Z O Hassan; Noor Tariq; Lili Zhang; Maryam Afshar; Dahlia Banerji; Connor P Mulligan; Adam Rokicki; Magid Awadalla; James L Januzzi; Tomas G Neilan
Journal:  Clin Infect Dis       Date:  2020-08-22       Impact factor: 9.079

Review 2.  Stimulant Drugs of Abuse and Cardiac Arrhythmias.

Authors:  Paari Dominic; Javaria Ahmad; Hajra Awwab; Md Shenuarin Bhuiyan; Christopher G Kevil; Nicholas E Goeders; Kevin S Murnane; James C Patterson; Kristin E Sandau; Rakesh Gopinathannair; Brian Olshansky
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-12-28

3.  Incidence, Predictors, and Outcomes of Implantable Cardioverter-Defibrillator Discharge Among People Living With HIV.

Authors:  Raza M Alvi; Anne M Neilan; Noor Tariq; Magid Awadalla; Adam Rokicki; Malek Hassan; Maryam Afshar; Connor P Mulligan; Virginia A Triant; Markella V Zanni; Tomas G Neilan
Journal:  J Am Heart Assoc       Date:  2018-09-18       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.